Characterization of Serous Retinopathy Associated with Cobimetinib: Integrated Safety Analysis of Four Studies

INTRODUCTION AND OBJECTIVE: Serous retinopathy can be associated with MEK inhibitors, including cobimetinib. We present results of an integrated safety analysis to further characterize ocular functional and structural changes due to serous retinopathy. METHODS: Four studies evaluating cobimetinib at...

Descripción completa

Detalles Bibliográficos
Autores principales: Barteselli, Giulio, Goodman, Grant R., Patel, Yogesh, Caro, Ivor, Xue, Cloris, McCallum, Samuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700562/
https://www.ncbi.nlm.nih.gov/pubmed/36310331
http://dx.doi.org/10.1007/s40264-022-01248-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700562/
https://www.ncbi.nlm.nih.gov/pubmed/36310331
http://dx.doi.org/10.1007/s40264-022-01248-2

Ejemplares similares